{"id":11186,"date":"2012-09-17T15:21:31","date_gmt":"2012-09-17T12:21:31","guid":{"rendered":"http:\/\/www.erzurumflas.com\/?p=11186"},"modified":"2012-09-18T00:27:59","modified_gmt":"2012-09-17T21:27:59","slug":"erkekler-kotu-haber","status":"publish","type":"post","link":"https:\/\/www.erzhaber.com.tr\/?p=11186","title":{"rendered":"Erkekler K\u00f6t\u00fc Haber"},"content":{"rendered":"

T\u00fcrk Radyoloji Derne\u011fi<\/a>\u00a0Genel Sekreteri ve Avrupa \u00dcrogenital Radyoloji Derne\u011fi Prostat Kanseri \u00c7al\u0131\u015fma Grubu \u00dcyesi\u00a0Do\u00e7. Dr. Ahmet Tuncay Turgut<\/strong><\/em>, her y\u0131l 36 erkekten birinin prostat kanserine yenik d\u00fc\u015ft\u00fc\u011f\u00fcn\u00fc bildirdi.<\/p>\n

17-23 Eyl\u00fcl D\u00fcnya\u00a0Prostat Haftas\u0131<\/strong><\/em>\u00a0dolay\u0131s\u0131yla yaz\u0131l\u0131 a\u00e7\u0131klama yapan\u00a0 Turgut, manyetik rezonans g\u00f6r\u00fcnt\u00fcleme ve multiparametrik manyetik rezonans teknolojisinde son d\u00f6nemde kaydedilen geli\u015fmeler sayesinde prostat kanserinin kolayl\u0131kla saptanabildi\u011fini ve t\u00fcm\u00f6r\u00fcn davran\u0131\u015f \u00f6zelliklerinin belirlenebildi\u011fini belirtti.<\/p>\n

<\/p>\n

Ya\u015fam beklentisinin artmas\u0131na paralel olarak \u00f6zellikle 65 ya\u015f \u00fczerinde olmak \u00fczere gelecek 30 y\u0131l i\u00e7inde kanser vakalar\u0131nda 3 kat art\u0131\u015f meydana gelece\u011finin hesapland\u0131\u011f\u0131n\u0131 ifade eden Turgut, bu durumun prostat kanserinde de ge\u00e7erli oldu\u011funu bildirdi.<\/p>\n

Turgut, prostat kanserinin genel olarak orta ya\u015f\u0131 ge\u00e7mi\u015f erkeklerde en s\u0131k tan\u0131 konan kanser t\u00fcr\u00fc oldu\u011funa dikkati \u00e7ekti. Bu hastal\u0131\u011f\u0131n t\u00fcm kanser vakalar\u0131n\u0131n y\u00fczde 11’inden ve kanserden \u00f6l\u00fcmlerin y\u00fczde 9’undan sorumlu oldu\u011funu kaydeden Do\u00e7.Dr. Turgut, ara\u015ft\u0131rmalar\u0131n her 6 erkekten birinin ya\u015fam\u0131 boyunca prostat kanserine yakalanaca\u011f\u0131n\u0131 g\u00f6sterdi\u011fini \u00f6ne s\u00fcrd\u00fc.<\/p>\n

<\/p>\n

D\u00fcnyada her y\u0131l 258 bin hasta hayat\u0131n\u0131 kaybediyor<\/strong><\/p>\n

Prostat kanserinin t\u00fcm d\u00fcnyada erkeklerde kansere ba\u011fl\u0131 \u00f6l\u00fcm nedenleri aras\u0131nda akci\u011fer kanserinden sonra en s\u0131k sorumlu tutulan ikinci hastal\u0131k konumunda oldu\u011funu bildiren Do\u00e7. Dr. Turgut, \u015fu bilgiyi verdi:<\/p>\n

”Bu \u00e7er\u00e7evede her 36 erkekten birinin prostat kanseri nedeniyle hayat\u0131n\u0131 kaybetti\u011fi d\u00fc\u015f\u00fcn\u00fclmektedir. T\u00fcm d\u00fcnyada y\u0131lda yakla\u015f\u0131k 900 bin hasta prostat kanseri tan\u0131s\u0131 al\u0131rken, her y\u0131l 258 bin hasta prostat kanseri nedeniyle hayat\u0131n\u0131 kaybetmektedir. Benzer \u015fekilde ABD’de 2012 i\u00e7in \u00f6ng\u00f6r\u00fclen yeni olgu say\u0131s\u0131 241 bin 740, \u00f6l\u00fcm say\u0131s\u0131 ise 28 bin 170’dir. Mevcut art\u0131\u015f trendinin devam etmesi durumunda 2030 y\u0131l\u0131nda d\u00fcnyada her y\u0131l 1,7 milyon yeni olgu ve 500 bin \u00f6l\u00fcm g\u00f6r\u00fclece\u011fi d\u00fc\u015f\u00fcn\u00fclmektedir. Prostat kanseri i\u00e7in bilinen en kuvvetli risk fakt\u00f6r\u00fc genetik fakt\u00f6rlerdir. Bu nedenle ailesinde prostat kanseri \u00f6yk\u00fcs\u00fc olanlar prostat kanseri i\u00e7in risk alt\u0131ndad\u0131r. Ayr\u0131ca di\u011fer baz\u0131 kanser t\u00fcrleri i\u00e7in oldu\u011fu gibi prostat kanserinin de bat\u0131 tipi ya\u015fam tarz\u0131, haz\u0131r g\u0131dalar\u0131n fazla t\u00fcketimi gibi al\u0131\u015fkanl\u0131klarla art\u0131\u015f g\u00f6sterdi\u011fi d\u00fc\u015f\u00fcn\u00fclmektedir. Genellikle 40 ya\u015f\u0131n \u00fcst\u00fcndeki erkeklerde g\u00f6r\u00fclen prostat kanseri erken d\u00f6nemde belirti vermeyip tan\u0131 ancak rutin kontroller s\u0131ras\u0131nda yap\u0131lan tetkiklerle konulabilmektedir.”<\/p>\n

<\/p>\n

Hastal\u0131k ”sinsi \u015fekilde” ilerliyor<\/strong><\/p>\n

Hastal\u0131\u011f\u0131n s\u0131kl\u0131kla ”sinsi \u015fekilde” ilerledikten sonra ge\u00e7 d\u00f6nemde kendini g\u00f6sterdi\u011fini bildiren Ahmet Tuncay Turgut, ”Ba\u015fl\u0131ca belirtiler aras\u0131nda yer alan idrardan kan gelmesi, meniye kan kar\u0131\u015fmas\u0131 gibi bulgular\u0131n varl\u0131\u011f\u0131 hastal\u0131\u011f\u0131n ilerledi\u011fini akla getirmektedir. G\u00fcn\u00fcm\u00fczde prostat kanseri erken evrede yakaland\u0131\u011f\u0131nda ve do\u011fru tedavi uyguland\u0131\u011f\u0131nda ba\u015far\u0131 oran\u0131 y\u00fczde 90’lara y\u00fckselmektedir. Yap\u0131lan ara\u015ft\u0131rmalarda tarama yoluyla prostat kanserinden \u00f6l\u00fcm oranlar\u0131n\u0131n y\u00fczde 30 oran\u0131nda azald\u0131\u011f\u0131 hesaplanm\u0131\u015ft\u0131r” ifadelerini kulland\u0131.<\/p>\n

<\/p>\n

T\u00fcrkiye’de durum<\/strong><\/p>\n

T\u00fcrkiye’de prostat hastal\u0131\u011f\u0131 verilerinin d\u00fcnya ile paralellik g\u00f6sterdi\u011fini ve hastal\u0131\u011f\u0131n g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131n\u0131n y\u00fczde 20 civar\u0131nda oldu\u011funu belirten Turgut, \u00e7al\u0131\u015fmalarda \u00fclkede de prostat kanserinde belirgin art\u0131\u015f oldu\u011funun belirlendi\u011fini \u00f6ne s\u00fcrd\u00fc.<\/p>\n

Do\u00e7.Dr. Turgut, prostat kanserinin erkeklerde akci\u011fer kanserinden sonra ikinci s\u0131raya yerle\u015fti\u011finin anla\u015f\u0131ld\u0131\u011f\u0131n\u0131 ifade etti.<\/p>\n

Turgut, T\u00fcrkiye’de bat\u0131 \u00fclkelerinden k\u0131smen farkl\u0131 olarak erken tan\u0131 oran\u0131n\u0131n halen \u00f6nemli \u00f6l\u00e7\u00fcde d\u00fc\u015f\u00fck oldu\u011funun s\u00f6ylenebilece\u011fini anlatarak, bu durumun ”hastal\u0131\u011fa y\u00f6nelik fark\u0131ndal\u0131\u011f\u0131n g\u00f6rece d\u00fc\u015f\u00fck olmas\u0131” ve ”\u00f6zellikle k\u00fclt\u00fcrel fakt\u00f6rlerle ili\u015fkili olmak \u00fczere hekime ba\u015fvurma oran\u0131n\u0131n istenen d\u00fczeyde olmamas\u0131ndan” kaynakland\u0131\u011f\u0131n\u0131 bildirdi.<\/p>\n","protected":false},"excerpt":{"rendered":"